Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Azienda Ospedaliera Universitaria Federico II - "Policlinico"

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Azienda Ospedaliera Universitaria Federico II - "Policlinico" is one of the largest and most prominent teaching hospitals in Southern Italy. It operates as an integral arm of the public Italian National Health Service while serving as the primary clinical training site for the School of Medicine and Surgery at the historic University of Naples Federico II. The hospital functions as an internationally recognized center of excellence and a key member of multiple European Reference Networks (ERN), holding particular regional and national expertise in neuromuscular diseases (such as ALS), rare endocrine diseases, oncology, cardiology, and inherited metabolic disorders.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Government hospital
Source: Trial-derived.
71Total Trials
Source: Trial-derived.
17Recruiting Trials
Source: Trial-derived.
23Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
115Unique Conditions
Source: Trial-derived.
53Unique Sponsors

Conditions

Source: Trial-derived. Multiple Sclerosis (4)Source: Trial-derived. Atrial Fibrillation (3)Source: Trial-derived. Breast Cancer (3)Source: Trial-derived. Coronary Artery Disease (3)Source: Trial-derived. Cystic Fibrosis (3)Source: Trial-derived. Metastatic Breast Cancer (3)Source: Trial-derived. Renal Insufficiency (3)Source: Trial-derived. Acromegaly (2)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (10)Source: Trial-derived. Federico II University (5)Source: Trial-derived. Bayer (4)Source: Trial-derived. Consorzio Oncotech (3)Source: Trial-derived. Daiichi Sankyo (3)Source: Trial-derived. MicroPort CRM (3)Source: Trial-derived. Vertex Pharmaceuticals Incorporated (3)Source: Trial-derived. Abbott Medical Devices (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood p-tau217 biomarker testing